[Press release] On February 1, the fourth and final call for incentives has opened, offering SMEs the chance to speed up their innovation. Life Sciences SMEs are invited to apply until May 4, 2014. A total of 164 incentives have been granted during the first three calls; 53 Collaboration, 29 Insight, 82 Meet and Greet. SMEs that wish to take part in the project can contact their Regional Access Broker or fill out an online application form.
KORILOG is a publisher of scientific software for sequence data analysis. The company offers a range of software based on KLAST, the new high-performance sequence similarity search technology created by Korilog and the Rennes INRIA1-IRISA2 research center. Through the network of Atlanpole Biotherapies, Korilog wants to accelerate its development by taking part in projects with the network members, both private and academic.
Advanced Accelerator Applications announced today that they have received orphan drug designation status for their radiopharmaceutical, Gallium-68 DOTATATE. The orphan drug designation has been granted by both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for use of Gallium-68 DOTATATE as a diagnostic agent for the management of Gastro-Entero- Pancreatic Neuroendocrine Tumors (GEP-NETs).